DOCSLIB.ORG

Annual Report 2006 Annual Report2006

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 2006 Annual Report2006 (incorporated in the Cayman Islands with limited liability) (Stock Code: 8222) Better Health Better Life Annual Report 2006 Annual Report2006 2 Dai Fu Street, Tai Po Industrial Estate, Hong Kong Tel: (852) 2126 1212 Fax: (852) 2126 1211 www.ck-lifesciences.com Characteristics of the Growth Enterprise Market (”GEM”) of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) GEM has been established as a market designed to accommodate companies to which a high investment risk may be attached. In particular, companies may list on GEM with neither a track record of profi tability nor any obligation to forecast future profi tability. Furthermore, there may be risks arising out of the emerging nature of companies listed on GEM and the business sectors or countries in which the companies operate. Prospective investors should be aware of the potential risks of investing in such companies and should make the This annual report (“Annual Report”) is available in both decision to invest only after due and careful consideration. English and Chinese. Shareholders who have received either The greater risk profi le and other characteristics of GEM the English or the Chinese version of the Annual Report mean that it is a market more suited to professional and other may request a copy in the language different from that has sophisticated investors. been received by writing to: Computershare Hong Kong Investor Services Limited, 46th Floor, Hopewell Centre, 183 Given the emerging nature of companies listed on GEM, there Queen’s Road East, Hong Kong. is a risk that securities traded on GEM may be more susceptible to high market volatility than securities traded on the Main The Annual Report (in both English and Chinese versions) Board and no assurance is given that there will be a liquid has been posted on the Company’s website at market in the securities traded on GEM. http://www.ck-lifesciences.com. Shareholders who have chosen to rely on copies of the Company’s corporate The principal means of information dissemination on GEM communication (including but not limited to annual report, is publication on the internet website operated by the Stock summary fi nancial report (where applicable), half-year Exchange. Listed companies are not generally required to issue report, summary half-year report (where applicable), paid announcements in gazetted newspapers. Accordingly, quarter report, notice of meeting, listing document, circular prospective investors should note that they need to have access and proxy form) posted on the Company’s website in lieu of to the GEM website in order to obtain up-to-date information the printed copies thereof may request the printed copy of on GEM-listed issuers. the Annual Report. This document, for which the Directors of CK Life Sciences Int’l., Shareholders who have chosen to receive the corporate (Holdings) Inc. (the “Company”) collectively and individually accept full communication using electronic means through the responsibility, includes particulars given in compliance with the Rules Company’s website and who for any reason have diffi culty Governing the Listing of Securities on the Growth Enterprise Market in receiving or gaining access to the Annual Report posted of The Stock Exchange of Hong Kong Limited for the purpose of giving on the Company’s website will promptly upon request be information with regard to the Company. The Directors, having made all sent the Annual Report in printed form free of charge. reasonable enquiries, confi rm that, to the best of their knowledge and belief: (i) the information contained in this document is accurate and complete in Shareholders may at any time choose to change your all material respects and is not misleading; (ii) there are no other matters the choice as to the means of receipt (i.e. in printed form or by omission of which would make any statement in this document misleading; electronic means through the Company’s website) and/or and (iii) all opinions expressed in this document have been arrived at after the language of the Company’s corporate communication by due and careful consideration and are founded on bases and assumptions notice in writing to the Company’s Branch Share Registrar, that are fair and reasonable. Computershare Hong Kong Investor Services Limited at 46th Floor, Hopewell Centre, 183 Queen’s Road East, Hong Kong. Contents 2 Corporate Profile 4 Achievement Highlights 6 2006 – Year in Review 8 Chairman’s Statement Business Review 12 Health 18 Agriculture 24 Directors and Senior Management 32 Financial Summary 33 Financial Review 35 Risk Factors 38 Report of the Directors 54 Corporate Governance Report 83 Independent Auditor’s Report 84 Consolidated Income Statement 85 Consolidated Balance Sheet 87 Consolidated Statement of Changes in Equity 88 Consolidated Cash Flow Statement 90 Notes to the Financial Statements 131 Principal Subsidiaries 134 Principal Associates 135 Corporate Information and Key Dates CK LIFE SCIENCES INT’L., (HOLDINGS) INC. ANNUAL REPORT 2006 1 Corporate Profile About CK Life Sciences CK Life Sciences has been listed on the Growth Enterprise Market of the Stock Exchange of Hong Kong Limited (stock code: 8222) since July 2002. Bearing the mission of improving the quality of life, the Group is engaged in the business of research and development, commercialization, marketing and sale of biotechnology products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. A number of the Group’s inventions have been granted patents by the US Patent and Trademark Office. CK Life Sciences has also been selected as one of 30 global “Technology Pioneers 2004” by the World Economic Forum. 2 CK LIFE SCIENCES INT’L., (HOLDINGS) INC. ANNUAL REPORT 2006 Better Health Better Life CK LIFE SCIENCES INT’L., (HOLDINGS) INC. ANNUAL REPORT 2006 3 Achievement Highlights Strong Growth Total Revenue 2,197 (HK$million) Increased 2 Times over 2005 +216% 694 05 06 4 CK LIFE SCIENCES INT’L., (HOLDINGS) INC. ANNUAL REPORT 2006 102 (HK$million) Profit Up 7 – fold over 2005 +734% 12 05 06 CK LIFE SCIENCES INT’L., (HOLDINGS) INC. ANNUAL REPORT 2006 5 2006 – Year in Review JAN – FEB CK Life Sciences acquired an 80% stake in Vitaquest International Holdings LLC, the largest custom contract nutraceutical manufacturer in the United States. MAR – APR The Adrien Gagnon or “AG” brand of natural health supplements was launched in Hong Kong. An extensive range of AG health products are now exclusively available at Watsons Your Personal Stores throughout the territory. MAY – JUNE A new distributor, PhilAgrow, Inc. was appointed in the Philippines to drive sales of NutriSmart®. 6 CK LIFE SCIENCES INT’L., (HOLDINGS) INC. ANNUAL REPORT 2006 2006 – Year in Review (cont’d) JUL – AUG NutriWizTM, a new fertilizer product developed by CK Life Sciences from microbial technology, was launched in Mainland China. Encouraging sales have been reported to date. SEP – OCT The AG Natural Health brand was launched in over 700 Kruidvat stores in the Netherlands. This represents CK Life Sciences’ first foray into the European market. Adrien Gagnon was the recipient of the “Gold Award” for “Bestselling Nutraceutical Brand” at Watsons 2006 7th Annual Health & Beauty Awards. At the same time, VitaGain® received the “Silver Award” in the “Bestselling ard" Food Brand in the Immunity Category”. NOV – DEC The latest VitaGain® products, Lingzhi Guard and Cordyceps Guard, were launched and have fast become popular items in the range. CK LIFE SCIENCES INT’L., (HOLDINGS) INC. ANNUAL REPORT 2006 7 Chairman’s Statement 2006 A Noteworthy Year It has been a very exciting year for CK Life Sciences, with achievements on all fronts. 1 Sales Up 2 /2 Times; Revenue Increased 2 Times; and Profit Grew 7 Times HK$’000 2006 2005 Variance Sales revenue 1,938,557 542,484 +257% Investment proceeds 258,561 151,895 +70% Total revenue 2,197,118 694,379 +216% Profit attributable to shareholders 102,022 12,234 +734% 8 CK LIFE SCIENCES INT’L., (HOLDINGS) INC. ANNUAL REPORT 2006 Chairman’s Statement (cont’d) 2006 marked a noteworthy year for CK Life Sciences: 1 Sales from environmental and health businesses about HK$2 billion; 2 Total revenue approaching HK$2.2 billion; 3 Profit attributable to shareholders over HK$100 million; 4 First full year contributions from the newly acquired Santé Naturelle A.G. Ltée in Canada and Envirogreen and Nuturf in Australia recorded; 5 Acquired Vitaquest, the largest custom contract nutraceutical manufacturer in the US, strengthening profit contribution for the Group; 6 Launched the Adrien Gagnon (or “AG”) nutraceutical brand internationally, firstly in Hong Kong in the earlier half of the year and then in the Netherlands in the second half. All in all, it has been a very exciting year for CK Life Sciences, with achievements on all fronts. We look forward to capitalizing on this momentum in 2007 and beyond. The financial performance of CK Life Sciences Int’l., Health Sales Up 10 Times (Holdings) Inc. (“CK Life Sciences” or the “Group”) for Sales from health-related business approached the year ended 31 December 2006 has been very strong. HK$1.4 billion, representing an increase of more than Sales revenue increased 21/ times to approximately 2 10 times over 2005. HK$2 billion, while investment proceeds increased 70% to The performance of our health business was boosted by approximately HK$260 million. Total revenue reached contributions from Vitaquest International Holdings LLC nearly HK$2.2 billion, an increase of more than 2 times (“Vitaquest”), which was acquired in early 2006. Vitaquest over last year. Profit attributable to shareholders grew generated strong results over the course of the year and 7-fold to HK$102 million. expanded the scope of our nutraceutical business.
Load more

Recommended publications
  • CK Hutchison Highlights of the Unaudited Results for the Six Months Ended 30 June 2015
    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document. Highlights of the Unaudited Results for the six months ended 30 June 2015 CKHH six months statutory results (1) For the six months ended 30 June 2015 HK$ millions Total Revenue 117,250 Profit attributable to ordinary shareholders from continuing business 21,477 Profit attributable to ordinary shareholders from discontinued business 80,381 Profit attributable to ordinary shareholders 101,858 Earnings per share – statutory (2) HK$39.87 CKHH six months management pro forma results (3) (compared to HWL results for businesses continued by CKHH) CKHH Results HWL Results for the six for the six months ended months ended 30 June 2015 30 June 2014 HK$ millions HK$ millions Change Total Revenue (4) 197,019 196,671 - Total EBITDA (4) 46,165 42,587 +8% Total EBIT (4) 30,677 26,815 +14% Profit attributable to ordinary shareholders before profits on disposal of investments & others (5) 14,938 10,220 +46% Profits on disposal of investments & others (482) 14,921 -103% Total profit attributable to ordinary shareholders (6) 14,456 25,141 -43% Recurring earnings per share – pro forma (7) HK$3.87 For the six months ended 30 June 2015 Interim dividend per share HK$0.70 CKHH 2015 Interim Results Page 1 of 98 Note (1) Statutory results of CK Hutchison Holdings Limited (“CKHH” or the “Group”) for the six months ended 30 June 2015 include the one-time effects of the Reorganisation that occurred on 3 June 2015.
    [Show full text]
  • Enhancing Everyday Living
    (Incorporated in the Cayman Islands with limited liability) (Stock Code: 0775) Annual Report 2017 Enhancing Everyday Living PHARMACEUTICAL 2 Dai Fu Street, Tai Po Industrial Estate, Hong Kong Tel: (852) 2126 1212 Fax: (852) 2126 1211 NUTRACEUTICAL www.ck-lifesciences.com Annual Report 2017 AGRICULTURE–RELATED About CK Life Sciences CK Life Sciences Int’l., (Holdings) Inc. is listed on The Stock Exchange of Hong Kong Limited. Bearing the mission of improving the quality of life, CK Life Sciences is engaged in the business of research and development, manufacturing, commercialisation, marketing, sale of, and investment in, products and assets which fall into three core categories – nutraceuticals, pharmaceuticals and agriculture-related. CK Life Sciences is a member of the CK Hutchison Group. Contents 2 Chairman’s Statement 6 Business Review Agriculture-related Business Nutraceutical Business Pharmaceutical Business 24 Long Term Development Strategy 25 Financial Summary 26 Financial Review 28 Directors and Key Personnel 35 Report of the Directors 46 Independent Auditor’s Report 52 Consolidated Income Statement 53 Consolidated Statement of Comprehensive Income 54 Consolidated Statement of Financial Position 56 Consolidated Statement of Changes in Equity 57 Consolidated Statement of Cash Flows 59 Notes to the Consolidated Financial Statements 124 Principal Subsidiaries 129 Principal Joint Ventures 130 Schedule of Major Investment Properties 131 Corporate Governance Report 163 Environmental, Social and Governance Report 173 Risk Factors 178 Corporate Information and Key Dates Chairman’s Statement 2 CK Life Sciences Int’l., (Holdings) Inc. For the year ended 31 December 2017, CK Life Sciences Int’l., (Holdings) Inc. (“CK Life Sciences” or the “Company”) reported profit attributable to shareholders of HK$258 million, an increase of 2% as compared to the Company’s restated profit1 in 2016.
    [Show full text]
  • CK Hutchison Holding(1
    Equity Market Hong Kong Equity Morning note Martin Ma (SFC CE:BOB758) (852) 3519 1055 Friday, September 25,2020 Market Wrap HSI▼1.82% HSCEI▼1.96% Turnover HK$117.16 bn ▼9% (30-day average) SSE Composite▼1.72% SZSE Component ▼2.24% Sector tracking Stock tracking 1D ▲% 1Y ▲% 1D ▲% 1Q ▲% Utilities 0.5 Automobiles 88.6 SOLARGIGA ENERGY(757) 38.0 NEXION TECHNOLOG(8420) 339.6 Real Estate 1.0 Durable & Tech 54.9 GOLDWAY EDUCATIO(8160) 21.4 HAINAN MEILAN IN(357) 286.2 GOLDWAY EDUCATIO HAINAN MEILAN IN Consumer Goods Health Care IN TECHNICAL PRO(8446) 1.4 49.8 CORNERSTONE FINA(8112) 20.0 227.1 CORNERSTONE FINA IN TECHNICAL PRO Capital Goods 1.4 Consumer Goods 29.2 CHINA ALUMINUM C(6898) 19.5 KNK HOLDINGS LTD(8039) 222.8 Telecom Services 1.6 Materials 25.6 ROYALCHINA CENTURY ALUMINUM RE(8125) C 18.2 YTOKNK EXPRESS HOLDINGS HOLD LTD(6123) 220.9 MarketROYAL CENTURY Highlight RE YTO EXPRESS HOLD Hong Kong Utilities Series 4 – CKGOLDWAY Hutchison EDUCATIO Holding(1 HK): CORNERSTONE FINA CK Hutchison Holding Limited is a CHINA ALUMINUM C Hutchison Telecommunications HK Holding multinational conglomerate that ROYAL CENTURY RE (0215 HK) operate variety sector of business in around 50 countries and have over CK Infrastructure Holding 300,000 employees around the world. (01038 HK) The business involve including Ports and related services, retail, infrastructure, Energy and Li Ka-shing Telecommunications. CK Hutchison Holding For the year 20201H, Hutchison Group (0001 HK) reported HK$ 189,942 million revenue, with YoY changes of -12%, HK$28,619 of total EBIT, with YoY changes of -21%.
    [Show full text]
  • 73 Watson Cover
    Quarter 3 & 4 • 2007 A.S. Watson quarterly73 family magazine Superdurg thinks pink Fresh look • innovative concept On tour with Marionnaud PARKnSHOP shares Olympic spirit Watsons invests in people Wats Our Aroundthe world Focusstory Home Ourcommunity Hutchstory tents With a history dating back to 1828, the A.S. Watson Group (ASW) has evolved into an international retail and manufacturing businessn with operations in 36 th Co Fresh look innovative Superdrug thinks pink ...... Reaching the 300 Small bears for big Li's donation a tribute to markets worldwide. Today, the Group owns more than 7,800 retail stores concept...... milestone...... benefits...... those who choose to running the gamut from health & beauty chains, luxury perfumeries & cosmetics serve...... to food, electronics, fine wine and airport retail arms. An established player 21 34 in the beverage industry, ASW provides a full range of beverages from bottled water, fruit juices, soft drinks and tea products to the world’s finest wine labels 27 38 via its international wine wholesaler and distributor. 05 ASW employs over 98,000 staff and is a member of the world renowned Hong Kong-based conglomerate Hutchison Whampoa Limited, which has five core businesses - ports and related services; property and hotels; retail; energy, About A.S. Watson Group About A.S. Watson infrastructure, investments and others; and telecommunications in 55 countries. Editorial committee Published by • Adviser : Dominic Lai • Members : A.S. Watson & Co., Limited Wats On is the quarterly family magazine of the A.S. Watson Group. • Editor : Malina Ngai Group Office – Anna Tam, Jenny Cabrol, Anthea Chau Watson House, 1-5 Wo Liu Hang Road, Fotan, Hong Kong Health & Beauty – Nuanphan Pat Jayanama, Rita Wong, Jessin Yeung Email: [email protected] Materials from this publication may only be reprinted with full © Copyright A.S.
    [Show full text]
  • Annual Report 2016
    CHEUNG KONG INFRASTRUCTURE HOLDINGS LIMITED 長江基建集團有限公司 (Incorporated in Bermuda with limited liability) (Stock Code: 1038) GLOBAL INFRASTRUCTURE PLAYER Annual Report 2016 A Leading Player in CKI the Global Infrastructure Arena CKI is a global infrastructure company that aims to make the world a better place through a variety of infrastructure investments and developments in different parts of the world. The Group has diversified investments in Energy Infrastructure, Transportation Infrastructure, Water Infrastructure, Waste Management, Waste-to-energy and Infrastructure Related Businesses. Its investments and operations span Hong Kong, Mainland China, the United Kingdom, the Netherlands, Portugal, Australia, New Zealand and Canada. CONTENTS 008 091 Ten-year Financial Summary Consolidated Statement of Comprehensive 010 Income Chairman’s Letter 092 016 Consolidated Statement of Financial Position Group Managing Director’s Report 093 021 Consolidated Statement of Changes in Equity Long Term Development Strategy 094 022 Consolidated Statement of Cash Flows Awards 095 026 Notes to the Consolidated Financial Statements Business Review 028 Investment in Power Assets 153 030 Infrastructure Investment in United Kingdom Principal Subsidiaries 036 Infrastructure Investment in Australia 040 Infrastructure Investment in New Zealand 154 Principal Associates 042 Infrastructure Investment in Continental Europe 045 Infrastructure Investment in Canada 156 048 Infrastructure Investment in Mainland China Principal Joint Ventures 050 Investment in Infrastructure
    [Show full text]
  • ENHANCING EVERYDAY LIVING Annual Report 2020
    (Incorporated in the Cayman Islands with limited liability) (Stock Code: 0775) Agriculture-related ENHANCING EVERYDAY LIVING Annual Report 2020 Nutraceutical Pharmaceutical ABOUT CK LIFE SCIENCES CK Life Sciences Int’l., (Holdings) Inc. is listed on The Stock Exchange of Hong Kong Limited. Bearing the mission of improving the quality of life, CK Life Sciences is engaged in the business of research and development, manufacturing, commercialisation, marketing, sale of, and investment in products and assets which fall into three core categories – nutraceuticals, pharmaceuticals and agriculture-related. CK Life Sciences is a member of the CK Hutchison Group. Contents 2 Chairman’s Statement 6 Business Review Agriculture-related Business Nutraceutical Business Pharmaceutical Research 24 Long Term Development Strategy 25 Financial Summary 26 Financial Review 28 Directors and Key Personnel 36 Report of the Directors 48 Independent Auditor’s Report 54 Consolidated Income Statement 55 Consolidated Statement of Comprehensive Income 56 Consolidated Statement of Financial Position 58 Consolidated Statement of Changes in Equity 59 Consolidated Statement of Cash Flows 61 Notes to the Consolidated Financial Statements 121 Principal Subsidiaries 125 Principal Joint Venture 126 Schedule of Major Investment Properties 127 Corporate Governance Report 163 Risk Factors 170 Corporate Information and Key Dates Chairman's Statement 2 CK Life Sciences Int'l., (Holdings) Inc. For the year ended 31 December 2020, CK Life took the opportunity to restructure the organisation Sciences Int’l., (Holdings) Inc. (“CK Life Sciences” or the and implement improvements which could facilitate “Company”) reported profit attributable to shareholders post-pandemic growth, including the commissioning of a of HK$125 million, a decrease of about 31% as compared new production facility, installation of new machines and to that of 2019 mainly due to the impact caused by implementation of software to streamline and promote COVID-19.
    [Show full text]
  • The Competitive Strategy of an Ethnic Chinese Corporate Group Under the Hong Kong Economic Development, with Special Emphasis on the Cheung Kong Group
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Ritsumeikan Research Repository © Institute of lnternational Relations and Area Studies, Ritsumeikan University The Competitive Strategy of an Ethnic Chinese Corporate Group under the Hong Kong Economic Development — With Special Emphasis on the Cheung Kong Group — Mori, Masaki* Abstract This paper discusses about the competitive strategy of an ethnic Chinese corporate group under the Hong Kong economic development, with special emphasis on the Cheung Kong group. First, Hong Kong economy, its industrial development and the economic relationship between Hong Kong and the mainland China is historically examined. Second, the growth strategy of a Hong Kong corporate group, the Cheung Kong group, is discussed how to diversify its business in adapting to Hong Kong economic environment. Third, the characteristics of its corporate governance and accounting management are discussed as a family-owned corporate group. Keywords: Competitive Strategy, Ethnic Chinese Corporate Group, the Hong Kong Economic Development, the Cheung Kong Group Ritsumeikan International Affairs Vol.12, pp.21–38 (2014). * Associate Professor, College of Business Administration, Ritsumeikan University, Japan. E-mail: [email protected] 22 Ritsumeikan International Affairs 【Vol. 12 1. Introduction This paper examines the Competitive Strategy of an ethnic Chinese corporate group under the Hong Kong economic development, through a case study of the Cheung Kong Group. The focus herein is on corporate governance and accounting management within family enterprises. You Zhongxun (1998) proposes that “The reason for the economic prosperity of ethnic Chinese…is largely attributable to Asia’s economic development.
    [Show full text]
  • Principal Subsidiary and Associated Companies and Joint Ventures at 31 December 2020
    Principal Subsidiary and Associated Companies and Joint Ventures at 31 December 2020 Nominal value of Place of incorporation / issued ordinary Percentage of Subsidiary and associated companies and principal place of share capital **/ equity attributable joint ventures operations registered capital to the Group Principal activities Ports and related services Alexandria International Container Terminals Egypt USD 30,000,000 59 Container terminal operating Company S.A.E. Amsterdam Container Terminals B.V. Netherlands EUR 18,400 80 Container terminal operating Brisbane Container Terminals Pty Limited Australia AUD 34,100,000 80 Container terminal operating Buenos Aires Container Terminal Services S.A. Argentina ARS 648,385,014 80 Container terminal operating ECT Delta Terminal B.V. Netherlands EUR 18,000 71 Container terminal operating Ensenada Cruiseport Village, S.A. de C.V. Mexico MXP 145,695,000 80 Cruise terminal operating Ensenada International Terminal, S.A. de C.V. Mexico MXP 160,195,000 80 Container terminal operating Europe Container Terminals B.V. Netherlands EUR 45,000,000 75 Holding company Euromax Terminal Rotterdam B.V. Netherlands EUR 100,000 49 Container terminal operating Freeport Container Port Limited Bahamas BSD 2,000 41 Container terminal operating Gdynia Container Terminal S.A. Poland PLN 11,379,300 80 Container terminal operating and rental of port real estate Harwich International Port Limited United Kingdom GBP 16,812,002 80 Container terminal operating ✡ Hongkong United Dockyards Limited Hong Kong HKD 76,000,000 50 Ship repairing, general engineering and tug operations ✡ 惠州港業股份有限公司 China RMB 300,000,000 27 Container terminal operating ✡ Huizhou Quanwan Port Development Co., Ltd.
    [Show full text]
  • Solid Foundation Fosters Long-Term Development
    20 1 7 Annual Report Solid Foundation Fosters Long-term Development 22nd Floor, Hutchison House, 10 Harcourt Road, Hong Kong Telephone: +852 2128 1188 2017 Annual Report Facsimile: +852 2128 1705 www.ckh.com.hk WorldReginfo - 7a0610cc-4251-4d12-8195-61d40b71508e Corporate Information CK Hutchison Holdings Limited BOARD OF DIRECTORS EXECUTIVE DIRECTORS NON-EXECUTIVE DIRECTORS Chairman CHOW Kun Chee, Roland, LLM LI Ka-shing, GBM, KBE, LLD (Hon), DSSc (Hon) CHOW WOO Mo Fong, Susan, BSc Commandeur de la Légion d’Honneur Grand Officer of the Order Vasco Nunez de Balboa LEE Yeh Kwong, Charles, GBM, GBS, OBE, JP Commandeur de l’Ordre de Léopold LEUNG Siu Hon, BA (Law) (Hons), LL.D. (Hon) Group Co-Managing Director and George Colin MAGNUS, OBE, BBS, MA Deputy Chairman LI Tzar Kuoi, Victor, BSc, MSc, LLD (Hon) INDEPENDENT NON-EXECUTIVE DIRECTORS Group Co-Managing Director KWOK Tun-li, Stanley, BSc (Arch), AA Dipl, LLD (Hon), ARIBA, MRAIC FOK Kin Ning, Canning, BA, DFM, FCA (ANZ) CHENG Hoi Chuen, Vincent, GBS, OBE, JP Frank John SIXT, MA, LLL The Hon Sir Michael David KADOORIE, GBS, LLD (Hon), DSc (Hon) Group Finance Director and Deputy Managing Director Commandeur de la Légion d’Honneur Commandeur de l’Ordre des Arts et des Lettres IP Tak Chuen, Edmond, BA, MSc Commandeur de l’Ordre de la Couronne Deputy Managing Director Commandeur de l’Ordre de Leopold II (William Elkin MOCATTA, FCA as his alternate) KAM Hing Lam, BSc, MBA Deputy Managing Director LEE Wai Mun, Rose, JP, BBA LAI Kai Ming, Dominic, BSc, MBA William SHURNIAK, S.O.M., M.S.M., LLD
    [Show full text]
  • Board and Key Personnel
    BOARD AND KEY PERSONNEL Executive Committee Front (from left to right) Andrew Hunter, H L Kam, Victor Li, Edmond Ip Back (from left to right) Joanna Chen, Pak Lam Lun, Lambert Leung, Dominic Chan, Ivan Chan, Victor Luk, Wendy Tong Barnes DIRECTORS’ BIOGRAPHICAL INFORMATION LI Tzar Kuoi, Victor aged 47, has been the Chairman of the Company since its incorporation in May 1996. He has been a member of the Remuneration Committee of the Company since March 2005 and acted as the Chairman of the Remuneration Committee of the Company from March 2005 to December 2011. He is also the Managing Director and Deputy Chairman of Cheung Kong (Holdings) Limited, Deputy Chairman of Hutchison Whampoa Limited, the Chairman of CK Life Sciences Int’l., (Holdings) Inc., an Executive Director of Power Assets Holdings Limited, Co-Chairman of Husky Energy Inc. and a Director of The Hongkong and Shanghai Banking Corporation Limited (“HSBC”). Except for HSBC, all the companies mentioned above are listed companies. Mr. Victor Li serves as a member of the Standing Committee of the 11th National Committee of the Chinese People’s Political Consultative Conference of the People’s Republic of China. He is also a member of the Commission on Strategic Development and the Council for Sustainable Development of the Hong Kong Special Administrative Region (“HKSAR”), and Vice Chairman of the Hong Kong General Chamber of Commerce. Mr. Victor Li is also the Honorary Consul of Barbados in Hong Kong. He is a director of certain substantial shareholders of the Company within the meaning of Part XV of the Securities and Futures Ordinance (“SFO”), and a director of certain companies controlled by certain substantial shareholders of the Company.
    [Show full text]
  • Cheung Kong Infrastructure Holdings Limited (“CKI”) Achieved Another Record Performance
    2013 Annual Annual Report Global Opportunities Global Solid Platform to Capitalise on Capitalise to Platform Solid CHEUNG KONG (HOLDINGS) LIMITED ANNUAL REPORT 2013 Group Structure Cheung Kong (Holdings) Limited 49.9% 45.3% 12.2% Hutchison Whampoa Limited CK Life Sciences Int’l., 24.47% TOM Group (Holdings) Inc. Limited 1.08% 65.01% 78.16% 71.36% Hutchison Telecommunications Cheung Kong Infrastructure Hutchison Harbour Hong Kong Holdings Limited Holdings Limited Ring Limited 38.9% Power Assets Holdings Limited CHEUNG KONG GROUP TOTAL MARKET CAPITALISATION HK$1,023 Billion 28th February, 2014 CONTENTS 1 Group Structure 2 Ten Year Financial Summary 3 Results Highlights 4 The Year at a Glance 10 Report of the Chairman and the Managing Director 15 Management Discussion and Analysis 24 Directors’ Biographical Information 28 Key Personnel’s Biographical Information 35 Risk Factors 39 Report of the Directors 54 Corporate Governance Report 78 Corporate Social Responsibility 84 Highlights of Development Projects 90 Schedule of Major Properties 96 Financial Statements 137 Independent Auditor’s Report 138 Listed Affi liated Companies Contents 144 Corporate Information and Key Dates 2 Ten Year Financial Summary 3 Results Highlights 4 The Year at a Glance 10 Report of the Chairman and the Managing Director 15 Management Discussion and Analysis 26 Directors’ Biographical Information 30 Key Personnel’s Biographical Information 38 Report of the Directors 55 Corporate Governance Report 84 Environmental, Social and Governance Report 96 Highlights of Development
    [Show full text]
  • E 8222Pro-20020704.Pdf
    IMPORTANT If you are in any doubt about this prospectus, you should consult your stockbroker, bank manager, solicitor, professional accountant or other professional adviser. A1 * PLACING AND PUBLIC OFFER Number of Offer Shares : 1,307,000,000 Shares (subject to under the Share Offer Over-allotment Option adjustment) Number of Placing Shares : 1,176,300,000 (subject to Over-allotment A15(1)(3) Option adjustment) (a) Number of Public Offer Shares : 130,700,000 (subject to reallocation) Offer Price : not more than HK$2.00 per Share A15(3)(c) payable in full on application Nominal Value : HK$0.10 each Sch3.I.9 Stock Code : 8222 A15(3)(c) LISTING ON THE GROWTH ENTERPRISE MARKET OF THE STOCK EXCHANGE OF HONG KONG LIMITED Global Co-ordinator, Sponsor and Lead Manager Co-Lead Managers BNP Paribas Peregrine BOCI Asia Limited CLSA / CIBC World Markets ICEA Capital Limited The Hongkong and Shanghai Banking Corporation Limited Co-Managers CEF Capital Limited China Everbright Capital Limited Core Pacific-Yamaichi International (H.K.) Limited FB Gemini Securities Ltd ING Bank N.V. SG Securities (HK) Ltd. South Capital Brokerage Limited Sun Hung Kai International Limited Worldsec International Limited The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this 14.04 prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever S.342C(2)(a) arising from or in reliance upon the whole or any part of the contents of this prospectus. A copy of this prospectus, having attached thereto the documents specified in the paragraph headed “Documents delivered to the Registrar of S.342C(1) Companies” in Appendix V, has been registered with the Registrar of Companies in Hong Kong as required by section 342C of the Companies S.342C(2)(b) Ordinance (Chapter 32 of the Laws of Hong Kong).
    [Show full text]